Protocol No
NU-20H09-NHL
Phase
II
Summary
To assess the anticancer effect of zanubrutinib with CAR-T therapy in aggressive lymphoma.
Description
Phase II Study Evaluating Adjunctive Zanubrutinib and CAR T-cell therapy in Aggressive B-cell Non-Hodgkins Lymphoma
Participating Institutions
Froedtert Hospital
Status
OPEN TO ACCRUAL
Categories
ClinicalTrials.gov